Research programme: RSV-influenza combination vaccine - Novavax

Drug Profile

Research programme: RSV-influenza combination vaccine - Novavax

Alternative Names: Combination seasonal influenza-RSV nanoparticle vaccine - Novavax; Combination seasonal influenza-RSV vaccine - Novavax; Combo RSV/Flu vaccine - Novavax; RSV-influenza nanoparticle vaccine - Novavax; RSV-influenza vaccine - Novavax; RSV/Flu vaccine - Novavax

Latest Information Update: 08 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novavax
  • Class Influenza virus vaccines; Protein-vaccines; Recombinant fusion proteins; Respiratory syncytial virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Influenza virus infections; Respiratory syncytial virus infections

Most Recent Events

  • 02 Jun 2016 Novavax plans a phase I/II trial for Influenza viral infections in USA
  • 12 Mar 2014 Preclinical trials in Influenza virus infections (prevention) in USA (Parenteral)
  • 12 Mar 2014 Preclinical trials in Respiratory syncytial virus infections (prevention) in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top